Description
Recombinant monoclonal antibody to CD86. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma BU63.
Target
CD86
Target Alias Names
B7.2, T lymphocyte activation antigen CD86, Activation B7-2 antigen, B72, B7-2, CTLA-4 counter-receptor B7.2
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression